Neostellar Capital Corp.
NSLR Nasdaq Financials FY2020–FY2025
Last close · Oct 23, 2026
$5.88
0.3%What Neostellar Capital Corp. does
No business description yet.
- Legal name
- Neostellar Capital Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 11, 2026
- Accession · CIK
- 0001493152-26-009641
0001509470
Revenue and margins
Neostellar Capital Corp. had — of revenue in fiscal 2025.
Net income and earnings per share
From fiscal 2020 to 2025, diluted EPS grew −12.9% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Neostellar Capital Corp. returned $12.0M to shareholders in fiscal 2025. The diluted share count rose 20.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Neostellar Capital Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $198M | $40.1M | $28.2M | $20.0M | $49.0M |
| Total assets | $462M | $284M | $278M | $232M | $276M |
| Total liabilities | $97.5M | $74.4M | $74.2M | $74.0M | $70.7M |
| Shareholders' equity | $365M | $210M | $203M | $158M | $205M |
| Net debt (− = net cash) | — | — | — | — | — |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✕ | ✓ | ✕ | ✓ |
| Cash from operations is positive | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ | ✓ | ✕ | ✓ |
| Cash from operations exceeds net income | ✕ | ✓ | ✓ | ✕ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | — | — |
| Current ratio rose | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✕ | ✓ | ✓ | ✕ |
| Gross margin rose | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | — | — | — | — |
| F-score | — / 3 | — / 4 | — / 5 | — / 5 | — / 5 | — / 5 |
| Accruals ratio | — | −7.9% | −5.8% | 1.0% | −15.9% | 5.7% |
| Altman Z'' | — | — | — | — | — | — |
6 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Interest expense | $2.2M | $0.7M | $4.8M | $4.9M | — | — |
| Income tax | $0.0M | $0.0M | $0.1M | $0.6M | $0.1M | −$0.2M |
| Net income | $75.3M | $147M | −$132M | $5.1M | −$38.1M | $48.8M |
| Diluted EPS | $3.56 | $5.52 | −$4.40 | $0.19 | −$1.60 | $1.78 |
| Diluted shares | 0.02B | 0.03B | 0.03B | 0.03B | 0.02B | 0.03B |
| Cash flow | ||||||
| Cash from operations | −$23.6M | $184M | −$111M | $2.4M | $2.4M | $34.3M |
| Stock-based compensation | $2.0M | $1.3M | $2.0M | $2.4M | $1.7M | $0.6M |
| Share buybacks | $10.4M | — | $21.5M | $14.2M | $9.4M | — |
| Dividends paid | $14.7M | $103M | $26.5M | $0.1M | $0.1M | $12.0M |
| Dividends and buybacks | $25.0M | $103M | $48.0M | $14.3M | $9.5M | $12.0M |
| Balance sheet | ||||||
| Cash and short-term investments | — | $198M | $40.1M | $28.2M | $20.0M | $49.0M |
| Total assets | — | $462M | $284M | $278M | $232M | $276M |
| Total liabilities | — | $97.5M | $74.4M | $74.2M | $74.0M | $70.7M |
| Shareholders' equity | — | $365M | $210M | $203M | $158M | $205M |
| Returns | ||||||
| Return on equity | — | 40.3% | −46.0% | 2.5% | −21.1% | 26.9% |
| Return on assets | — | 31.8% | −35.4% | 1.8% | −15.0% | 19.2% |
| Return on tangible equity | — | 40.3% | −62.9% | 2.5% | −24.2% | 23.8% |
| Growth | ||||||
| Net income growth | — | 95.2% | −189.9% | — | −852.4% | — |
| EPS growth | — | 55.1% | −179.7% | — | −942.1% | — |
| Share count change | — | 22.8% | 12.2% | −12.7% | −8.9% | 20.4% |
| Quality scores | ||||||
| Accruals ratio | — | −7.9% | −5.8% | 1.0% | −15.9% | 5.7% |
Source: SEC EDGAR XBRL filings (CIK 0001509470). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
